285 related articles for article (PubMed ID: 16221160)
1. Humoral immune response after kidney transplantation is enhanced by acute rejection and urological obstruction and is down-regulated by mycophenolate mofetil treatment.
Oliveira JG; Monteiro MS; Teixeira JF; Osório E; Norton SM; Alves H; Pestana M
Transpl Int; 2005 Nov; 18(11):1286-91. PubMed ID: 16221160
[TBL] [Abstract][Full Text] [Related]
2. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection.
Theruvath TP; Saidman SL; Mauiyyedi S; Delmonico FL; Williams WW; Tolkoff-Rubin N; Collins AB; Colvin RB; Cosimi AB; Pascual M
Transplantation; 2001 Jul; 72(1):77-83. PubMed ID: 11468538
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
[TBL] [Abstract][Full Text] [Related]
4. Influence of HLA disparity, immunosuppressive regimen used, and type of kidney allograft on production of anti-HLA class-I antibodies after transplant and occurrence of rejection.
Abdelnoor AM; Ajib R; Chakhtoura M; Daouk M; Medawar W; Uwaydah M; Sawah SI; Khauli RB
Immunopharmacol Immunotoxicol; 2009; 31(1):83-7. PubMed ID: 18752168
[TBL] [Abstract][Full Text] [Related]
5. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
[TBL] [Abstract][Full Text] [Related]
6. Effects of mycophenolate mofetil on donor-specific antibody formation in renal transplantation.
Lederer SR; Friedrich N; Banas B; Welser G; Albert ED; Sitter T
Clin Transplant; 2005 Apr; 19(2):168-74. PubMed ID: 15740551
[TBL] [Abstract][Full Text] [Related]
7. Randomized, prospective trial of mycophenolate mofetil versus azathioprine for prevention of acute renal allograft rejection after simultaneous kidney-pancreas transplantation.
Merion RM; Henry ML; Melzer JS; Sollinger HW; Sutherland DE; Taylor RJ
Transplantation; 2000 Jul; 70(1):105-11. PubMed ID: 10919583
[TBL] [Abstract][Full Text] [Related]
8. Formation of donor-specific human leukocyte antigen antibodies after kidney transplantation: correlation with acute rejection and tapering of immunosuppression.
van der Mast BJ; van Besouw NM; Witvliet MD; de Kuiper P; Smak Gregoor P; van Gelder T; Weimar W; Claas FH
Transplantation; 2003 Mar; 75(6):871-7. PubMed ID: 12660517
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
Gonwa T; Johnson C; Ahsan N; Alfrey EJ; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; VanVeldhuisen P; Leonhardt M; Fitzsimmons WE
Transplantation; 2003 Jun; 75(12):2048-53. PubMed ID: 12829910
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review.
Knight SR; Russell NK; Barcena L; Morris PJ
Transplantation; 2009 Mar; 87(6):785-94. PubMed ID: 19300178
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil in pediatric renal transplantation.
Otukesh H; Sharifian M; Basiri A; Simfroosh N; Hoseini R; Sedigh N; Golnari P; Rezai M; Fereshtenejad M
Transplant Proc; 2005 Sep; 37(7):3012-5. PubMed ID: 16213289
[TBL] [Abstract][Full Text] [Related]
13. Improvement in long-term graft survival in cadaveric renal transplant recipients treated with mycophenolate mofetil.
Hazzan M; Provot F; Glowacki F; Copin MC; Roumilhac D; Labalette M; Pruvot FR; Noel C
Transpl Int; 2004 Oct; 17(9):525-30. PubMed ID: 15338120
[TBL] [Abstract][Full Text] [Related]
14. Mycophenolate mofetil for prevention of liver allograft rejection: initial results of a controlled clinical trial.
Sterneck M; Fischer L; Gahlemann C; Gundlach M; Rogiers X; Broelsch C
Ann Transplant; 2000; 5(1):43-6. PubMed ID: 10850611
[TBL] [Abstract][Full Text] [Related]
15. Screening for de novo anti-human leukocyte antigen antibodies in nonsensitized kidney transplant recipients does not predict acute rejection.
Gill JS; Landsberg D; Johnston O; Shapiro RJ; Magil AB; Wu V; Tinckam K; Keown P
Transplantation; 2010 Jan; 89(2):178-84. PubMed ID: 20098280
[TBL] [Abstract][Full Text] [Related]
16. sCD30 and neopterin as risk factors of chronic renal transplant rejection: impact of cyclosporine A, tacrolimus, and mycophenolate mofetil.
Weimer R; Süsal C; Yildiz S; Streller S; Pelzl S; Staak A; Renner F; Dietrich H; Daniel V; Feuring E; Kamali-Ernst S; Ernst W; Padberg W; Opelz G
Transplant Proc; 2005 May; 37(4):1776-8. PubMed ID: 15919463
[TBL] [Abstract][Full Text] [Related]
17. [Mycophenolate mofetil (MMF) for prevention of kidney transplant rejection. A new immunosuppressive agent. International Mycophenolate Mofetil Study Group].
Carl S; Wiesel M; Staehler G
Urologe A; 1998 May; 37(3):282-6. PubMed ID: 9646426
[TBL] [Abstract][Full Text] [Related]
18. The influence of mycophenolate mofetil versus azathioprine and mycophenolic acid pharmacokinetics on the incidence of acute rejection and infectious complications after renal transplantation.
Satoh S; Tada H; Murakami M; Tsuchiya N; Inoue T; Togashi H; Matsuura S; Hayase Y; Suzuki T; Habuchi T
Transplant Proc; 2005 May; 37(4):1751-3. PubMed ID: 15919454
[TBL] [Abstract][Full Text] [Related]
19. Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil.
Sun Q; Liu ZH; Cheng Z; Chen J; Ji S; Zeng C; Li LS
Kidney Int; 2007 Jan; 71(1):24-30. PubMed ID: 16969384
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil vs azathioprine in a large population of elderly renal transplant patients.
Meier-Kriesche HU; Morris JA; Chu AH; Steffen BJ; Gotz VP; Gordon RD; Kaplan B
Nephrol Dial Transplant; 2004 Nov; 19(11):2864-9. PubMed ID: 15496562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
